Alvarado v. Morgan Stanley Dean Witter, Inc.

448 F. Supp. 2d 333, 2006 U.S. Dist. LEXIS 64202, 2006 WL 2587496
CourtDistrict Court, D. Puerto Rico
DecidedAugust 30, 2006
DocketCIV. 05-1149(JP)
StatusPublished
Cited by2 cases

This text of 448 F. Supp. 2d 333 (Alvarado v. Morgan Stanley Dean Witter, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Puerto Rico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Alvarado v. Morgan Stanley Dean Witter, Inc., 448 F. Supp. 2d 333, 2006 U.S. Dist. LEXIS 64202, 2006 WL 2587496 (prd 2006).

Opinion

OPINION AND ORDER

PIE RAS, Senior District Judge.

The plaintiffs bring federal claims of securities fraud against Morgan Stanley Dean Witter, alleging that a Morgan Stanley broker sold them securities with the intent to misappropriate the invested funds. Morgan Stanley moves to dismiss the complaint on the grounds that the plaintiffs failed to state a claim under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and under Rule 10b-5, promulgated by the Securities Exchange Commission. The court denies the motion, and holds that the plaintiffs stated claims for agency liability under Section 10(b) and Rule 10b-5, and for controlling person liability under Section 20(a).

I. FACTUAL ALLEGATIONS

Carlos Soto was employed by Morgan Stanley as a financial advisor and broker, and occupied the position of First Vice President of Investments at Morgan Stanley’s San Juan branch. In 2001 the plaintiffs, a married couple, followed Soto’s advice to invest in a GNMA fund through Morgan Stanley. Soto told the plaintiffs the fund was a low risk investment, and would yield an eight percent annual return. He also told them the GNMA investment account would activate a check *335 ing account at Morgan Stanley, into which the couple could deposit funds. The plaintiffs decided to chose to invest in the GNMA fund, because of Morgan Stanley’s “good name and standing in the industry.” They assumed Soto was trustworthy, and that Morgan Stanley carefully screened, and supervised its brokers. The plaintiffs told Soto that the investment was for the purpose of creating a college fund for their daughters. On May 9, 2001, the plaintiffs visited Soto at his office at Morgan Stanley, and handed him a check for $1,015,000.00 made payable to Morgan Stanley. The plaintiffs instructed Soto to invest $1,000,000.00 in the GNMA fund, and to deposit the remaining $15,000.00 in the checking account which would be activated with the GNMA investment. Soto told the plaintiffs that the interest earned on the GNMA fund would be deposited into the checking account each month, and that they would receive a receipt of their investment by mail. The check was deposited into a Morgan Stanley account at Bank of America. The plaintiffs received by mail a document titled “Statement of Your Account” with the Morgan Stanley logo, which indicated they had invested $1,000,000.00 in GNMA securities.

After the plaintiffs’ made their investment, Soto commingled the money deposited by the plaintiffs with his own personal bank accounts and business entities, and manipulated the Morgan Stanley monthly statements to avoid detection. The plaintiffs’ monthly statements from Morgan Stanley indicated that from September 13, 2002, until February, 2004, they received monthly deposits into their checking account in the amount of $4,777.53. The monthly statements did not indicate what persons or entities made deposits into the plaintiffs’ checking account, and the plaintiffs believed these deposits represented interest on their GNMA investment. However, at least once per month Soto transferred funds from his personal accounts into the plaintiffs’ Morgan Stanley checking account in order to cover the plaintiffs’ expected interest payment. Soto engaged in the same conduct with other clients’ accounts, and established an independent accounting system which indicated the amount of monies diverted from client accounts. His actions finally came to light on February 9, 2004, when he confessed to Morgan Stanley personnel that he had engaged in a scheme to divert Morgan Stanley investors’ money for personal use and to engage in risky and speculative trading on his own behalf. Morgan Stanley eventually paid a $6 million fine levied by the New York Stock Exchange for their failures to supervise Soto, monitor customer accounts, and maintain accurate records.

The plaintiffs allege Soto’s and Morgan Stanley’s actions caused them to lose over $650,000 in principal and interest on their GNMA investment, and also caused them to incur emotional damages. They claim Morgan Stanley is liable for securities fraud under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and under SEC Rule 10b-5, and for negligence, and breach of fiduciary duty under Article 1803 of the Puerto Rico Constitution.

II. ANALYSIS

When considering a motion to dismiss, the district court must “assume the truth of all well-pleaded facts and indulge all reasonable inferences that fit the plaintiffs stated theory of liability.” In re Colonial Mortg. Bankers Corp., 324 F.3d 12, 15 (1st Cir.2003). The court is free to disregard “bald assertions, unsupportable conclusions, and opprobrious epithets.” In re Credit Suisse First Boston Corp., 431 F.3d 36, 45 (1st Cir.2005). In addition, a “complaint sufficiently raises a claim even if it points to no legal theory or even if it *336 points to the wrong legal theory as a basis for that claim, as long as relief is possible under any set of facts that could be established consistent with the allegations.” González-Pérez v. Hospital Interamericano De Medicina Avanzada, 355 F.3d 1, 5 (1st Cir.2004).

A. Section 10(b)

The elements of a claim under Section 10(b) are that the defendant (1) made a material misrepresentation or omission, (2) with scienter, (3) in connection with the purchase or sale of a security, (4) on which the plaintiff relied, (5) to his or her detriment. Dura Pharms., Inc. v. Broudo, 544 U.S. 336, 341-342, 125 S.Ct. 1627, 161 L.Ed.2d 577 (2005). To establish scienter a plaintiff must show that the defendant’s conduct evinced either a conscious intent to commit the alleged fraud or a high degree of recklessness in connection with the fraud. In re Credit Suisse First Boston Corp., 431 F.3d at 48 n. 5. To satisfy the final “loss” element, a plaintiff must show both economic loss and loss causation, i.e. a causal connection between the material misrepresentation or omission and the loss.

To survive a motion to dismiss a Section 10(b) complaint must satisfy the pleading standards of the Private Securities Litigation Reform Act (PSLRA). With respect to the element of scienter, a complaint must “state with particularity facts giving rise to a strong inference that the defendant acted with the required state of mind.” 15 U.S.C. § 78u-4(b)(2). Where a plaintiff alleges the defendant omitted to state material facts necessary to make statements made not misleading, the complaint must “specify each statement alleged to have been misleading, the reason or reasons why the statement is misleading, and, if an allegation regarding the statement or omission is made on information and belief, the complaint shall state with particularity all facts on which that belief is formed.” 15 U.S.C. § 78u-4(b)(1).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
448 F. Supp. 2d 333, 2006 U.S. Dist. LEXIS 64202, 2006 WL 2587496, Counsel Stack Legal Research, https://law.counselstack.com/opinion/alvarado-v-morgan-stanley-dean-witter-inc-prd-2006.